Table 1 Baseline characteristics of patients
From: Influence of apelin-12 on troponin levels and the rate of MACE in STEMI patients
Parameters | |
|---|---|
Age (year), mean (±SD) | 60.52 ± 11.50 |
Gender (male), n (%) | 60 (60) |
Medical history | |
Hypertension, n (%) | 59 (59) |
Diabetes mellitus, n (%) | 19 (19) |
Dyslipidemia, n (%) | 32 (32) |
Smoking, n (%) | 32 (32) |
Family history of cardiovascular disease, n (%) | 20 (20) |
Killip class >1, n (%) | 13 (13) |
Ejection fraction, mean (±SD) | 50.34 ± 10.20 |
Laboratory values | |
Haemolobin (g/dL), mean (±SD) | 13.54 ± 1.39 |
Creatinine (umol/L), median (range) | 92.90 (67.21–124.34) |
Apelin 12 on the first day (ng/mL), median (range) | 2.98 (0.45–15.25) |
Apelin 12 on the seventh day (ng/mL), median (range) | 2.33 (0.26–10.90) |
Troponin I on the first day (ng/mL), mean (±SD) | 54.80 ± 60.99 |
Troponin I on the seventh day (ng/mL), mean (±SD) | 12.43 ± 24.48 |
Coronary angiographic findings | |
Culprit lesion, n (%) | |
RCA | 40 (40) |
LAD | 48 (48) |
LCx | 12 (12) |
Vessel disease, n (%) | |
1 | 40 (40) |
2 | 31 (31) |
3 | 29 (29) |